Back to CVE records
Critical 9.8Published Mar 30, 2026

CVE-2026-30313DSAI-Cline's command auto-approval module contains a critical OS command injection vulnerability that renders its whitelist security mechanism completely ineffective.

Updated under an hour ago ()

Does this affect you?

It affects cline. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

DSAI-Cline's command auto-approval module contains a critical OS command injection vulnerability that renders its whitelist security mechanism completely ineffective. The system relies on string-based parsing to validate commands; while it intercepts dangerous operators such as ;, &&, ||, |, and command substitution patterns, it fails to account for raw newline characters embedded within the input. An attacker can construct a payload by embedding a literal newline between a whitelisted command and malicious code (e.g., git log malicious_command), forcing DSAI-Cline to misidentify it as a safe operation and automatically approve it. The underlying PowerShell interpreter treats the newline as a command separator, executing both commands sequentially, resulting in Remote Code Execution without any user interaction.

CVSS
9.8 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-94
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Jun 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
cline cline
cline:cline
through 1.1.2
NVD

References

  • third-party-advisory
  • product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.